Avoidant/restrictive food intake disorder prognosis and its relation with autism spectrum disorder in Japanese children
Pediatrics International · 2025-01 · 67 (1)
DOI: 10.1111/ped.70040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatrics International, online erschienen am 14.05.2025. Verfasst von Chie Tanaka und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan. Hauptthemen laut MEDLINE: Autism Spectrum Disorder, Avoidant Restrictive Food Intake Disorder. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Children and Families Agency Program.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
There is a lack of reported clinical factors associated with the outcomes of children and adolescents with avoidant/restrictive food intake disorder (ARFID) in Japan. This study aimed to identify these clinical factors and explore the relationship between ARFID and autism spectrum disorder (ASD).
Methods
This retrospective study analyzed data from 48 Japanese children and adolescents with ARFID who visited Okayama University Hospital between January 2011 and March 2022. Clinical characteristics were assessed using medical records and natural history questionnaires. The study compared patients with good and poor prognosis groups and used multiple logistic regression analysis to determine factors influencing prognosis.
Results
The study included 33 patients with good prognoses and 15 with poor prognoses. Comorbid ASD was more prevalent in the poor prognosis group (60%) compared to the good prognosis group (21%). Additionally, more than half of the ARFID patients with comorbid ASD were initially undiagnosed. Multivariate analysis revealed that older age at first visit ( p = 0.022) and comorbid ASD ( p = 0.022) were statistically significant factors associated with poor prognosis in ARFID patients. There were no significant differences in body mass index standard deviation score and maximal weight loss between the two groups.
Conclusions
The poor prognosis group had a higher prevalence of comorbid ASD diagnoses. Therefore, it is crucial to evaluate patient's developmental characteristics early in treatment and consider these characteristics throughout the course of care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
- Clinical Psychology Section, Department of Medical Support, Okayama University Hospital, Okayama, Japan.
- Department of Child Welfare, Notre Dame Seishin University, Okayama, Japan.
- Department of Epidemiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
ORCID-Profile: Chie Tanaka
Förderung
- Children and Families Agency Program
Zitieren
APA
Tanaka, C., Okada, A., Hanzawa, M., Fujii, C., Shigeyasu, Y., Sugihara, A., Horiuchi, M., Yorifuji, T., & Tsukahara, H. (2025). Avoidant/restrictive food intake disorder prognosis and its relation with autism spectrum disorder in Japanese children. Pediatrics International, 67(1). https://doi.org/10.1111/ped.70040
Vancouver
Tanaka C, Okada A, Hanzawa M, Fujii C, Shigeyasu Y, Sugihara A, et al. Avoidant/restrictive food intake disorder prognosis and its relation with autism spectrum disorder in Japanese children. Pediatrics International. 2025;67(1). doi:10.1111/ped.70040
BibTeX
@article{Tanaka2025,
author = {Tanaka, Chie and Okada, Ayumi and Hanzawa, Mana and Fujii, Chikako and Shigeyasu, Yoshie and Sugihara, Akiko and Horiuchi, Makiko and Yorifuji, Takashi and Tsukahara, Hirokazu},
title = {Avoidant/restrictive food intake disorder prognosis and its relation with autism spectrum disorder in Japanese children},
journal = {Pediatrics International},
year = {2025},
volume = {67},
number = {1},
doi = {10.1111/ped.70040}
}
EUVIMED